LRS Outflows Surge Over 10 in March 2026 as Travel Demand and Investments Drive Capital Abroad
Paul McCartneys Final Appearance Highlights CBSs Financial Decision to End Colberts Late Show
Sell in May Pattern May Influence Crypto Markets as Seasonal Headwinds Approach
Satirical Cockroach Party Reports Website Blocked Potential Free Speech and Regulatory Concerns in India
Goldman Sachs Exits Apple Card Partnership Stock Enters Potential Buy Zone
Alibaba Unveils NextGen Zhenwu AI Chip and New Large Language Model
ZGN Q4 2025 Earnings EPS Beat Drives Stock Higher Despite Revenue Disclosures Lacking
Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses
RIGL Q1 2026 Earnings EPS Misses Estimates by 369 Stock Slips
aka Brands Holding Corp AKA Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uptick
STLA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges
VRSN Q1 2026 Earnings Earnings Beat Expectations Driven by Domain Base Stability
Agriculture Natural Solutions Acquisition Corporation ANSC Holds Steady at 1136 Trading Within Established Range
Novanta NOVT Shares Surge 311 as Recovery Tests Key Resistance at 16769
Mayville Engineering MEC Surges 7 Key Levels and Technical Outlook
CCLDO Preferred Shares Hold Steady at 2744 as Fixed Income Dynamics Support Stability
FG Imperii Acquisition Corp FGII Holds Steady Near Trust Value as SPAC Investors Await Merger Catalyst
Rail Vikas Nigam Suzlon ONGC Among Key Companies Set to Declare Q4 Results Next Week
AMTD Q4 2020 Earnings EPS Surges Past Estimates Amid Strong Performance
Sphere Entertainment SPHR Fades From Resistance A Test of Support Levels
GLMD Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges
SLVM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Industry Headwinds
Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues
FOLD Q4 2025 Earnings EPS Falls Short of Estimates Stock Unchanged
HCXY Q1 2026 Earnings Slight EPS Miss Triggers Modest Price Gain
SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development
NEU Q1 2026 Earnings Strong EPS of 1262 Shares Advance 332